Literature DB >> 19699020

Neurofunctional correlates of personality traits in relapsing-remitting multiple sclerosis: an fMRI study.

Maria C Gioia1, Antonio Cerasa, Paola Valentino, Francesco Fera, Rita Nisticò, Maria Liguori, Pierluigi Lanza, Aldo Quattrone.   

Abstract

Extraversion and Neuroticism are two fundamental dimensions of human personality that influence cognitive functioning in healthy subjects. Little is known about personality changes that may occur in patients with multiple sclerosis (MS) nor about, in particular, their neurofunctional basis. The aim of this study is to determine the impact of personality characteristics on brain activity in patients with MS. Eighteen patients with clinically definite relapsing-remitting MS without any evidence of psychiatric or cognitive disorders and thirteen healthy controls matched for age, gender and education were investigated using functional magnetic resonance imaging (fMRI) during the execution of an "n-back" task. No differences were detected on the behavioral tests between the two groups, although the MS patients had lower total IQ and showed a trend towards higher Extraversion and Neuroticism scores than did the controls. fMRI analyses demonstrated that Extraversion scores were positively associated with brain activity in the fronto-parietal network including the superior parietal lobule and dorsolateral prefrontal cortex in both groups during the high load condition of the n-back task. Given the overlapping neural systems found in the two groups, we suggest that the neural activity associated with specific personality dimension is a neurophysiological characteristic preserved in patients with MS at an early stage in the course of their disease.

Entities:  

Mesh:

Year:  2009        PMID: 19699020     DOI: 10.1016/j.bandc.2009.07.009

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  6 in total

1.  The Effect of Type D Personality on Quality of Life in Patients with Multiple Sclerosis.

Authors:  Seden Demirci; Kadir Demirci; Serpil Demirci
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

2.  The Relation of Questionnaire and Performance-Based Measures of Executive Functioning With Type 1 Diabetes Outcomes Among Late Adolescents.

Authors:  Yana Suchy; Sara L Turner; Tara L Queen; Kara Durracio; Deborah J Wiebe; Jonathan Butner; Emilie I Franchow; Perrin C White; Mary A Murray; Michael Swinyard; Cynthia A Berg
Journal:  Health Psychol       Date:  2016-05-12       Impact factor: 4.267

3.  Association of personality traits with physical function, cognition, and mood in multiple sclerosis.

Authors:  Anne Kever; Elizabeth L S Walker; Claire S Riley; Rock A Heyman; Zongqi Xia; Victoria M Leavitt
Journal:  Mult Scler Relat Disord       Date:  2022-02-03       Impact factor: 4.339

4.  The Big Five Personality Traits and Positive Orientation in Polish Adults with Multiple Sclerosis: The Role of Meaning in Life.

Authors:  Małgorzata Szcześniak; Andrzej Potemkowski; Waldemar Brola; Zdzisław Kroplewski; Roman Ryszard Szałachowski; Marek Zak; Maciej Wilski; Piotr Sobolewski; Halina Bartosik-Psujek; Katarzyna Kapica-Topczewska; Joanna Tarasiuk; Agata Czarnowska; Alina Kułakowska; Beata Zakrzewska-Pniewska; Katarzyna Kubicka-Bączyk; Natalia Morawiec; Monika Adamczyk-Sowa; Adam Stępień; Jacek Zaborski; Anna Ratajczak; Marcin Ratajczak
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 4.614

5.  The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.

Authors:  Francesco Fera; Luca Passamonti; Antonio Cerasa; Maria Cecilia Gioia; Maria Liguori; Ida Manna; Paola Valentino; Aldo Quattrone
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

6.  Robust prediction of individual personality from brain functional connectome.

Authors:  Huanhuan Cai; Jiajia Zhu; Yongqiang Yu
Journal:  Soc Cogn Affect Neurosci       Date:  2020-05-19       Impact factor: 3.436

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.